Aquestive Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AQST Nasdaq 2834 www.aquestive.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aquestive Therapeutics, Inc.

Aquestive Therapeutics to Participate in Citizens Life Sciences Conference - May 5th, 2025 11:00 am
Aquestive Therapeutics to Report First Quarter 2025 Financial Results and Recent Business Highlights on May 12 and Host Conference Call on May 13 at 8:00 a.m. ET - May 1st, 2025 11:00 am
Strength Seen in Recursion Pharmaceuticals (RXRX): Can Its 27.7% Jump Turn into More Strength? - Apr 14th, 2025 1:09 pm
Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium - Apr 9th, 2025 11:00 am
Aquestive Therapeutics Announces Positive Topline PK Results from its Pediatric Study and Completes the NDA Submission for Anaphylm™ (epinephrine) Sublingual Film - Apr 1st, 2025 11:00 am
Earnings Update: Aquestive Therapeutics, Inc. (NASDAQ:AQST) Just Reported And Analysts Are Trimming Their Forecasts - Mar 8th, 2025 12:29 pm
Aquestive Therapeutics Inc (AQST) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Mar 7th, 2025 7:07 am
Compared to Estimates, Aquestive Therapeutics (AQST) Q4 Earnings: A Look at Key Metrics - Mar 5th, 2025 11:30 pm
Aquestive Therapeutics (AQST) Reports Q4 Loss, Lags Revenue Estimates - Mar 5th, 2025 10:10 pm
Aquestive Therapeutics: Q4 Earnings Snapshot - Mar 5th, 2025 9:18 pm
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - Mar 5th, 2025 9:01 pm
Aquestive Therapeutics to Participate in Two Upcoming Conferences in March - Feb 26th, 2025 12:00 pm
Aquestive Therapeutics to Report Fourth Quarter 2024 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET - Feb 20th, 2025 12:00 pm
Strength Seen in United Therapeutics (UTHR): Can Its 4.9% Jump Turn into More Strength? - Feb 13th, 2025 3:13 pm
Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual Meeting - Feb 12th, 2025 12:00 pm
Aquestive Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Conference - Feb 4th, 2025 12:00 pm
Institutional investors own a significant stake of 49% in Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Jan 27th, 2025 10:48 am
Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives - Jan 13th, 2025 12:00 pm
Aquestive Therapeutics Gains FDA Orphan Drug Exclusivity for Pediatric Seizure Treatment - Dec 19th, 2024 4:40 pm
Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five - Dec 19th, 2024 1:00 pm